2021-11-222021-11-222006Ersoy, A. vd. (2006). ''Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus''. Nephrology Dialysis Transplantation, 21(2), 553-554.0931-0509https://doi.org/10.1093/ndt/gfi205https://academic.oup.com/ndt/article/21/2/553/1850702http://hdl.handle.net/11452/22762eninfo:eu-repo/semantics/openAccessTransplantationUrology & nephrologyTherapyRenal dialysisMiddle agedDiabetes mellitus, type 2Failure, chronicKidneyInsulinHypoglycemic agentsHumansFemaleInsulin analogue usage in a haemodialysis patient with type 2 diabetes mellitusArticle0002347829000572-s2.0-3154446463055355421216221693TransplantationUrology & nephrologyGlycosylated Albumin; Peritoneal Dialysis; HemodialysisLong acting drugIsophane insulinInsulin lisproInsulin glargineInsulin derivativeHemoglobin A1cPriority journalNon insulin dependent diabetes mellitusLetterKidney failureInsulin treatmentHypoglycemiaHyperinsulinemiaHumanHemodialysisGlucose homeostasisFemaleDrug dose regimenDrug costClinical featureCase reportAdult